BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 27184143)

  • 1. Prediction models for cardiovascular disease risk in the general population: systematic review.
    Damen JA; Hooft L; Schuit E; Debray TP; Collins GS; Tzoulaki I; Lassale CM; Siontis GC; Chiocchia V; Roberts C; Schlüssel MM; Gerry S; Black JA; Heus P; van der Schouw YT; Peelen LM; Moons KG
    BMJ; 2016 May; 353():i2416. PubMed ID: 27184143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
    Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease risk prediction models in the Chinese population- a systematic review and meta-analysis.
    Zhiting G; Jiaying T; Haiying H; Yuping Z; Qunfei Y; Jingfen J
    BMC Public Health; 2022 Aug; 22(1):1608. PubMed ID: 35999550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One Heartbeat Away from a Prediction Model for Cardiovascular Diseases in Patients with Chronic Kidney Disease: A Systematic Review.
    Smit LCM; Bots ML; van der Leeuw J; Damen JAAG; Blankestijn PJ; Verhaar MC; Vernooij RWM
    Cardiorenal Med; 2023; 13(1):109-142. PubMed ID: 36806550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of the Framingham risk models and pooled cohort equations for predicting 10-year risk of cardiovascular disease: a systematic review and meta-analysis.
    Damen JA; Pajouheshnia R; Heus P; Moons KGM; Reitsma JB; Scholten RJPM; Hooft L; Debray TPA
    BMC Med; 2019 Jun; 17(1):109. PubMed ID: 31189462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study.
    Slieker RC; van der Heijden AAWA; Siddiqui MK; Langendoen-Gort M; Nijpels G; Herings R; Feenstra TL; Moons KGM; Bell S; Elders PJ; 't Hart LM; Beulens JWJ
    BMJ; 2021 Sep; 374():n2134. PubMed ID: 34583929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review of prognostic prediction models for acute kidney injury (AKI) in general hospital populations.
    Hodgson LE; Sarnowski A; Roderick PJ; Dimitrov BD; Venn RM; Forni LG
    BMJ Open; 2017 Sep; 7(9):e016591. PubMed ID: 28963291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.
    Vernooij LM; van Klei WA; Moons KG; Takada T; van Waes J; Damen JA
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013139. PubMed ID: 34931303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction models for endometrial cancer for the general population or symptomatic women: A systematic review.
    Alblas M; Velt KB; Pashayan N; Widschwendter M; Steyerberg EW; Vergouwe Y
    Crit Rev Oncol Hematol; 2018 Jun; 126():92-99. PubMed ID: 29759571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction models for cardiovascular disease risk in the hypertensive population: a systematic review.
    Cai R; Wu X; Li C; Chao J
    J Hypertens; 2020 Sep; 38(9):1632-1639. PubMed ID: 32251200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic models for predicting relapse or recurrence of major depressive disorder in adults.
    Moriarty AS; Meader N; Snell KI; Riley RD; Paton LW; Chew-Graham CA; Gilbody S; Churchill R; Phillips RS; Ali S; McMillan D
    Cochrane Database Syst Rev; 2021 May; 5(5):CD013491. PubMed ID: 33956992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic models for outcome prediction in patients with chronic obstructive pulmonary disease: systematic review and critical appraisal.
    Bellou V; Belbasis L; Konstantinidis AK; Tzoulaki I; Evangelou E
    BMJ; 2019 Oct; 367():l5358. PubMed ID: 31585960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk prediction models for women in the general population: A systematic review.
    Baart SJ; Dam V; Scheres LJJ; Damen JAAG; Spijker R; Schuit E; Debray TPA; Fauser BCJM; Boersma E; Moons KGM; van der Schouw YT;
    PLoS One; 2019; 14(1):e0210329. PubMed ID: 30620772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis.
    Allotey J; Snell KI; Smuk M; Hooper R; Chan CL; Ahmed A; Chappell LC; von Dadelszen P; Dodds J; Green M; Kenny L; Khalil A; Khan KS; Mol BW; Myers J; Poston L; Thilaganathan B; Staff AC; Smith GC; Ganzevoort W; Laivuori H; Odibo AO; Ramírez JA; Kingdom J; Daskalakis G; Farrar D; Baschat AA; Seed PT; Prefumo F; da Silva Costa F; Groen H; Audibert F; Masse J; Skråstad RB; Salvesen KÅ; Haavaldsen C; Nagata C; Rumbold AR; Heinonen S; Askie LM; Smits LJ; Vinter CA; Magnus PM; Eero K; Villa PM; Jenum AK; Andersen LB; Norman JE; Ohkuchi A; Eskild A; Bhattacharya S; McAuliffe FM; Galindo A; Herraiz I; Carbillon L; Klipstein-Grobusch K; Yeo S; Teede HJ; Browne JL; Moons KG; Riley RD; Thangaratinam S
    Health Technol Assess; 2020 Dec; 24(72):1-252. PubMed ID: 33336645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice.
    Schoofs MC; Akkermans RP; de Grauw WJ; Schalk BW; van Dis I; Tjin-A-Ton J; Bischoff EW; Biermans MC
    Br J Gen Pract; 2023 Jan; 73(726):e24-e33. PubMed ID: 36443066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External validation and comparison of four cardiovascular risk prediction models with data from the Australian Diabetes, Obesity and Lifestyle study.
    Albarqouni L; Doust JA; Magliano D; Barr EL; Shaw JE; Glasziou PP
    Med J Aust; 2019 Mar; 210(4):161-167. PubMed ID: 30656697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A newly developed and externally validated non-clinical score accurately predicts 10-year cardiovascular disease risk in the general adult population.
    Schiborn C; Kühn T; Mühlenbruch K; Kuxhaus O; Weikert C; Fritsche A; Kaaks R; Schulze MB
    Sci Rep; 2021 Oct; 11(1):19609. PubMed ID: 34608230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a prediction model for fatal and non-fatal coronary heart disease and cardiovascular disease in patients with newly diagnosed type 2 diabetes mellitus: the Basque Country Prospective Complications and Mortality Study risk engine (BASCORE).
    Piniés JA; González-Carril F; Arteagoitia JM; Irigoien I; Altzibar JM; Rodriguez-Murua JL; Echevarriarteun L;
    Diabetologia; 2014 Nov; 57(11):2324-33. PubMed ID: 25212259
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 31.